מקורות

1. European Pharmacopoeia 8.0. Strasbourg: Council of Europe; Mastic, p. 1311.
2. Al-Habbal MJ, Al-Habbal Z, Huwez FU. A double-blind controlled clinical trial of mastic and placebo in the treatment of duodenal ulcer. Clin Exp Pharmacol Physiol. 1984 Sep-Oct;11(5):541-4. https://pubmed.ncbi.nlm.nih.gov/6395994/
3. Al-Said MS, Ageel AM, Parmar NS, Tariq M. Evaluation of mastic, a crude drug obtained from Pistacia lentiscus for gastric and duodenal anti-ulcer activity. J Ethnopharmacol. 1986 Mar;15(3):271-8. https://pubmed.ncbi.nlm.nih.gov/3724207/ 
4. Iauk L, Ragusa S, Rapisarda A, Franco S, Nicolosi VM. In vitro antimicrobial activity of Pistacia lentiscus L. extracts: preliminary report. J Chemother. 1996 Jun;8(3):207-9. https://pubmed.ncbi.nlm.nih.gov/8808717/ 
5. Kaliora AC, Stathopoulou MG, Triantafillidis JK, Dedoussis GV, Andrikopoulos NK. Chios mastic treatment of patients with active Crohn’s disease. World J Gastroenterol. 2007 Feb 7;13(5):748-53.https://pmc.ncbi.nlm.nih.gov/articles/PMC4066008/
6. Floris S, Di Petrillo A, Pintus F, Delogu GL. Pistacia lentiscus: Phytochemistry and Antidiabetic Properties. Nutrients. 2024 May 27;16(11):1638. https://pmc.ncbi.nlm.nih.gov/articles/PMC11174566/
7. Takahashi K, Fukazawa M, Motohira H, Ochiai K, Nishikawa H, Miyata T. A pilot study on antiplaque effects of mastic chewing gum in the oral cavity. J Periodontol. 2003 Apr;74(4):501-5.  https://pubmed.ncbi.nlm.nih.gov/12747455/ 
8. Soulaidopoulos S, Tsiogka A, Chrysohoou C, Lazarou E, Aznaouridis K, Doundoulakis I, Tyrovola D, Tousoulis D, Tsioufis K, Vlachopoulos C, Lazaros G. Overview of Chios Mastic Gum (Pistacia lentiscus) Effects on Human Health. https://pmc.ncbi.nlm.nih.gov/articles/PMC8838553/
9. EMA/HMPC/248074/2012. London: European Medicines Agency; Mastic. 2013.https://www.ema.europa.eu/en/documents/herbal-report/final-assessment-report-pistacia-lentiscus-l-resin-mastic_en.pdf